USMAN RAMZAN: Open Payments
NPI 1356387823 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 10 payments from 6 companies in 2025. Trend: 2023 $649 · 2024 $100 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Novo Nordisk Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
Products named: Veozah, BREZTRI, Wegovy, ZEPBOUND, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across CT — which companies pay providers there.
